Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

Samiksha Fouzdar Jain,1 Helen H Song,2 Shaza N Al-Holou,2 Linda A Morgan,1 Donny W Suh1,2 1Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA; 2Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA Purpose: The treatment of retinopath...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fouzdar Jain S, Song HH, Al-Holou SN, Morgan LA, Suh DW
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	retinopathy of prematurity (ROP) intravitreal bevacizumab (IVB) neonatal intensive care unit (NICU) Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ae8ab133191f45e1ac10e498b8d9833b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ae8ab133191f45e1ac10e498b8d9833b
record_format	dspace
spelling	oai:doaj.org-article:ae8ab133191f45e1ac10e498b8d9833b2021-12-02T03:03:36ZRetinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists1177-5483https://doaj.org/article/ae8ab133191f45e1ac10e498b8d9833b2018-05-01T00:00:00Zhttps://www.dovepress.com/retinopathy-of-prematurity-preferred-practice-patterns-among-pediatric-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Samiksha Fouzdar Jain,1 Helen H Song,2 Shaza N Al-Holou,2 Linda A Morgan,1 Donny W Suh1,2 1Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA; 2Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA Purpose: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. Methods: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. Results: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. Conclusion: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug. Keywords: retinopathy of prematurity, intravitreal bevacizumab, neonatal intensive care unit, laser photoablationFouzdar Jain SSong HHAl-Holou SNMorgan LASuh DWDove Medical Pressarticleretinopathy of prematurity (ROP)intravitreal bevacizumab (IVB)neonatal intensive care unit (NICU)OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 1003-1009 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	retinopathy of prematurity (ROP) intravitreal bevacizumab (IVB) neonatal intensive care unit (NICU) Ophthalmology RE1-994
spellingShingle	retinopathy of prematurity (ROP) intravitreal bevacizumab (IVB) neonatal intensive care unit (NICU) Ophthalmology RE1-994 Fouzdar Jain S Song HH Al-Holou SN Morgan LA Suh DW Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
description	Samiksha Fouzdar Jain,1 Helen H Song,2 Shaza N Al-Holou,2 Linda A Morgan,1 Donny W Suh1,2 1Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA; 2Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA Purpose: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. Methods: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. Results: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. Conclusion: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug. Keywords: retinopathy of prematurity, intravitreal bevacizumab, neonatal intensive care unit, laser photoablation
format	article
author	Fouzdar Jain S Song HH Al-Holou SN Morgan LA Suh DW
author_facet	Fouzdar Jain S Song HH Al-Holou SN Morgan LA Suh DW
author_sort	Fouzdar Jain S
title	Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_short	Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_full	Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_fullStr	Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_full_unstemmed	Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_sort	retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/ae8ab133191f45e1ac10e498b8d9833b
work_keys_str_mv	AT fouzdarjains retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT songhh retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT alholousn retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT morganla retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT suhdw retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists
_version_	1718402003372081152

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

Ejemplares similares